Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES CIPLA SUVEN LIFE SCIENCES/
CIPLA
 
P/E (TTM) x -10.7 27.5 - View Chart
P/BV x 13.2 3.7 352.9% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 SUVEN LIFE SCIENCES   CIPLA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-22
CIPLA
Mar-22
SUVEN LIFE SCIENCES/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1241,083 11.5%   
Low Rs70806 8.7%   
Sales per share (Unadj.) Rs0.8269.7 0.3%  
Earnings per share (Unadj.) Rs-8.431.7 -26.5%  
Cash flow per share (Unadj.) Rs-8.144.8 -18.1%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs6.6257.8 2.6%  
Shares outstanding (eoy) m145.38806.81 18.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x119.63.5 3,414.6%   
Avg P/E ratio x-11.629.8 -39.0%  
P/CF ratio (eoy) x-12.021.1 -57.1%  
Price / Book Value ratio x14.73.7 402.0%  
Dividend payout %015.8 0.0%   
Avg Mkt Cap Rs m14,164762,177 1.9%   
No. of employees `000NANA-   
Total wages/salary Rs m21035,299 0.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m118217,633 0.1%  
Other income Rs m533,217 1.7%   
Total revenues Rs m172220,851 0.1%   
Gross profit Rs m-1,22243,298 -2.8%  
Depreciation Rs m4410,520 0.4%   
Interest Rs m71,064 0.6%   
Profit before tax Rs m-1,22034,933 -3.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m09,338 0.0%   
Profit after tax Rs m-1,22025,595 -4.8%  
Gross profit margin %-1,032.219.9 -5,188.0%  
Effective tax rate %026.7 0.0%   
Net profit margin %-1,030.011.8 -8,758.3%  
BALANCE SHEET DATA
Current assets Rs m1,605147,108 1.1%   
Current liabilities Rs m1,02249,129 2.1%   
Net working cap to sales %492.145.0 1,093.0%  
Current ratio x1.63.0 52.4%  
Inventory Days Days1,40262 2,277.3%  
Debtors Days Days4006 6,964.3%  
Net fixed assets Rs m414119,248 0.3%   
Share capital Rs m1451,614 9.0%   
"Free" reserves Rs m816206,364 0.4%   
Net worth Rs m961207,977 0.5%   
Long term debt Rs m04,162 0.0%   
Total assets Rs m2,019266,523 0.8%  
Interest coverage x-181.133.8 -535.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.10.8 7.2%   
Return on assets %-60.110.0 -600.7%  
Return on equity %-126.912.3 -1,031.1%  
Return on capital %-126.217.0 -743.7%  
Exports to sales %44.726.2 170.4%   
Imports to sales %933.68.2 11,413.0%   
Exports (fob) Rs m5357,094 0.1%   
Imports (cif) Rs m1,10617,803 6.2%   
Fx inflow Rs m5360,180 0.1%   
Fx outflow Rs m1,10617,803 6.2%   
Net fx Rs m-1,05342,376 -2.5%   
CASH FLOW
From Operations Rs m-1,27533,259 -3.8%  
From Investments Rs m-222-18,719 1.2%  
From Financial Activity Rs m1,457-15,998 -9.1%  
Net Cashflow Rs m-41-1,323 3.1%  

Share Holding

Indian Promoters % 69.6 13.5 516.9%  
Foreign collaborators % 0.0 20.1 -  
Indian inst/Mut Fund % 0.6 49.5 1.3%  
FIIs % 0.5 27.4 1.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 66.5 45.8%  
Shareholders   78,634 475,293 16.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Suven Life Sciences vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Suven Life Sciences vs Cipla Share Price Performance

Period Suven Life Sciences Cipla S&P BSE HEALTHCARE
1-Day 0.85% 0.10% 0.72%
1-Month 0.12% 5.36% 4.36%
1-Year -19.78% -2.24% 8.18%
3-Year CAGR 21.58% 14.83% 14.99%
5-Year CAGR -19.40% 13.18% 13.29%

* Compound Annual Growth Rate

Here are more details on the Suven Life Sciences share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Suven Life Sciences hold a 69.6% stake in the company. In case of Cipla the stake stands at 33.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Suven Life Sciences and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Suven Life Sciences paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Cipla paid Rs 5.0, and its dividend payout ratio stood at 15.8%.

You may visit here to review the dividend history of Suven Life Sciences, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 119 Points Higher | Nykaa Gains 7%, Zomato 3% | Hindalco & Hero MotoCorp Among Top Gainers Sensex Today Ends 119 Points Higher | Nykaa Gains 7%, Zomato 3% | Hindalco & Hero MotoCorp Among Top Gainers(Closing)

After opening the day flat, Indian share markets picked up pace as session progressed and ended the day higher.